Cat. #158068
Anti-TLV
Cat. #: 158068
Unit size: 100 ug
Target: Tilapia Lake Virus
Class: Polyclonal
Application: ELISA
Reactivity: Virus
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Abdo Alnabulsi
Institute: Vertebrate Antibodies Limited
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-TLV
- Research fields: Cell biology;Immunology
- Class: Polyclonal
- Conjugation: Unconjugated
- Molecular weight: 38
- Reactivity: Virus
- Host: Rabbit
- Application: ELISA
- Description: Tilapia lake virus (TiLV) is an enveloped, negative-sense, single-stranded RNA virus. TiLV appears to cause disease mainly in tilapia and tilapia hybrids (Oreochromis spp., Tilapia spp.), but has also been detected causing disease in other wild cichlids (Sarotherodon galilaeus, Tristramella spp.). This virus is found to be transmitted through direct horizontal transmission by cohabitation or transfer of live aquatic animals. Clinical signs of virus include behavioral changes, skin damage such as erosion, discolouration, skin hemorrhages and loss of scales, eyeball protrusion (exophthalmia) and abdominal swelling. There are currently no treatment or vaccines for TiLV. As the spread of TiLV has global impact in both commercial and ecological settings, anti-TLV can be a useful tool for virus detecting and further application such as disease prevention, treatment monitor and vaccine development. The antibody is a valuable research tool TiLV diagnostics, epidemiological monitoring and vaccine development.
- Immunogen: Ovalbumin-conjugated synthetic peptide.
- Recommended controls: ELISA: peptide immunogen
Target Details
- Target: Tilapia Lake Virus
- Molecular weight: 38
- Target background: Tilapia lake virus (TiLV) is an enveloped, negative-sense, single-stranded RNA virus. TiLV appears to cause disease mainly in tilapia and tilapia hybrids (Oreochromis spp., Tilapia spp.), but has also been detected causing disease in other wild cichlids (Sarotherodon galilaeus, Tristramella spp.). This virus is found to be transmitted through direct horizontal transmission by cohabitation or transfer of live aquatic animals. Clinical signs of virus include behavioral changes, skin damage such as erosion, discolouration, skin hemorrhages and loss of scales, eyeball protrusion (exophthalmia) and abdominal swelling. There are currently no treatment or vaccines for TiLV. As the spread of TiLV has global impact in both commercial and ecological settings, anti-TLV can be a useful tool for virus detecting and further application such as disease prevention, treatment monitor and vaccine development. The antibody is a valuable research tool TiLV diagnostics, epidemiological monitoring and vaccine development.
Applications
- Application: ELISA
Handling
- Format: Liquid
- Unit size: 100 ug
- Storage buffer: Unpurified anti-serum from rabbit preserved in 0.02% Thiomersal
- Shipping conditions: Shipping at 4° C
